default author photo

F. Stephen Hodi

Harvard University - Melanoma Center

Boston, MA

United States

  • Harvard University - Melanoma Center

SCHOLARLY PAPERS

3

DOWNLOADS

191

TOTAL CITATIONS

5

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Durvalumab, Tremelimumab Alone or in Combination With Low-Dose or Hypofractionated Targeted Radiotherapy in Metastatic Non-Small Cell Lung Cancer Refractory to Prior PD-1 Therapy: A Multicentre, Open-Label, Randomized, Phase 2 Trial

Number of pages: 44 Posted: 13 Sep 2021
Jonathan D. Schoenfeld, Jonathan D. Schoenfeld, Anita Giobbie-Hurder, Srinika Ranasinghe, Katrina Z. Kao, Ana Lako, Junko Tsuji, Yang Liu, Ryan C. Brennick, Ryan Gentzler, Carrie Lee, Joleen Hubbard, James L. Abbruzzese, Salma K. Jabbour, Nataliya Uboha, Kevin Stephans, Jennifer M. Johnson, Haesong Park, Lisa C. Villaruz, Elad Sharon, Howard Streicher, Mansoor Ahmed, Hayley Lyon, Carrie Cibuskis, Niall Lennon, Aashna Jhaveri, Lin Yang, Jennifer Altreuter, Lauren Gunasti, Jason L. Weirather, Raymond H. Mak, Mark M. Awad, Scott J. Rodig, Helen X. Chen, Catherine J. Wu, Arta M. Monjazeb and F. Stephen Hodi
Harvard University - Brigham and Women's HospitalHarvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Massachusetts Institute of Technology and Harvard University - Broad Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, University of Virginia, Mayo Clinic, Duke University - Duke Cancer Institute, Rutgers University, New Brunswick - Rutgers Cancer Institute of New Jersey, University of Wisconsin School of Medicine, Cleveland Clinic, Thomas Jefferson University Hospital, Siteman Cancer Center, University of Pittsburgh - Medical Center (UPMC), Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the Italian Republic (Italy) - National Cancer Institute, Massachusetts Institute of Technology and Harvard University - Broad Institute, Massachusetts Institute of Technology and Harvard University - Broad Institute, Massachusetts Institute of Technology and Harvard University - Broad Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Dana-Farber Cancer Institute - Department of Data Science, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Government of the United States of America - National Cancer Institute, Harvard University - Dana-Farber Cancer Institute, University of California, Davis - Department of Radiation Oncology and Harvard University - Melanoma Center
Downloads 93 (725,554)
Citation 5

Abstract:

Loading...

2.

Integrated Clinico-Genomic Analysis of Genetic Ancestry in 1,614 Patients With Cancer Treated With Immune Checkpoint Inhibitors

Number of pages: 57 Posted: 11 Feb 2022
Amin Nassar, Elio Adib, Sarah Abou Alaiwi, Talal El Zarif, Stefan Groha, Elie W. Akl, Pier Vitale Nuzzo, Tarek H. Mouhieddine, Habib El-Khoury, Muhieddine Labban, Chris Labaki, Wenxin Xu, Guru Sonpavde, Robert I. Haddad, Kent W. Mouw, Marios Giannakis, F. Stephen Hodi, Laura E. MacConaill, Guruprasad Ananda, David J. Kwiatkowski, Toni K. Choueiri, Deborah Schrag and Alexander Gusev
Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Division of Population Sciences, Harvard University - Department of Medicine, Harvard University - Lank Center for Genitourinary Oncology, Mount Sinai Health System - Division of Hematology and Medical Oncology, Harvard University - Center for Prevention of Progression of Blood Cancers, Harvard University - Department of Urologic Surgery, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Radiation Oncology, Harvard University - Department of Medical Oncology, Harvard University - Melanoma Center, Harvard University - Department of Pathology, Harvard University - Department of Data Science, Harvard University - Department of Medicine, Harvard University - Lank Center for Genitourinary Oncology, Harvard University - Division of Genetics and Harvard University - Division of Population Sciences
Downloads 54 (1,020,567)

Abstract:

Loading...

Genetic ancestry, cancer, Immunotherapy, immune checkpoint inhibitors

3.

Mass Cytometry – Based Cytotoxicity Assay for Profiling Natural Killer Cells

Number of pages: 37 Posted: 23 Sep 2021
Elizabeth P. Gabriel, Alyssa Masciarelli, Jiajia Chen, Charlotte Abrecht, Margaret Hallisey, Martha Brainard, Han Dong, Jenna Dennis, Emma Hathaway, Mubin Tarannum, Juliana A. Vergara, Abigail N. Schork, Kevin Tyan, Giuseppe Tarantino, David Liu, Rizwan Romee, Osama E. Rahma, F. Stephen Hodi, Mariano Severgnini and Joanna K. Baginska
Dana-Farber Cancer Institute - Department of Medical Oncology, Dana-Farber Cancer Institute - Department of Medical Oncology, Dana-Farber Cancer Institute - Department of Medical Oncology, Dana-Farber Cancer Institute - Department of Medical Oncology, Dana-Farber Cancer Institute - Department of Medical Oncology, Dana-Farber Cancer Institute - Department of Medical Oncology, Harvard University - Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute - Department of Medical Oncology, Dana-Farber Cancer Institute - Department of Medical Oncology, Dana-Farber Cancer Institute - Division of Hematologic Malignancies, Dana-Farber Cancer Institute - Division of Hematologic Malignancies, Dana-Farber Cancer Institute - Longwood Medical Area CyTOF Core, Dana-Farber Cancer Institute - Department of Medical Oncology, Dana-Farber Cancer Institute - Department of Medical Oncology, Dana-Farber Cancer Institute - Department of Medical Oncology, Dana-Farber Cancer Institute - Division of Hematologic Malignancies, Dana-Farber Cancer Institute - Department of Medical Oncology, Harvard University - Melanoma Center, Dana-Farber Cancer Institute - Department of Medical Oncology and Dana-Farber Cancer Institute - Department of Medical Oncology
Downloads 44 (1,133,231)

Abstract:

Loading...

Innate Immunity, mass cytometry, NK cells, granzyme B transfer, cytotoxicity